Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on...How Best to Test for Heritable Cancer-Related Genetic Mutations: With Kenneth Offit, MD, Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center

  Sarah DiGiulio

• Free

  AMV564 Receives Orphan Drug Designation for AML
• Free

  Avelumab (Bavencio®)

  Sara K. Butler PharmD, BCPS, BCOP

• Free

  Brentuximab Vedotin Approved for Type of Lymphoma
• Free

  Cancer Overrides the Circadian Clock to Survive
• Free

  Cardio-Oncology Programs an Essential Part of Patient Care

  Heather Lindsey

• Free

  Carfilzomib Can Lead to Cardiovascular Toxicity in Multiple Myeloma Patients
• Free

  First-Line Combo Therapy Improves PFS in Advanced Lung Cancer
• Free

  Genetic Alteration Allows Lung Cancers to Escape the Immune System
• Free

  Guidance on Genetic Counseling & Testing for Hereditary Prostate Cancer
• Free

  Mechanism Behind Metabolic Vulnerability of Some Breast Cancers
• Free

  More Tumor Mutations Equal Higher Success Rates With Immunotherapy
• Free

  New Assay May Help Predict Which Pancreatic Lesions Become Cancerous
• Free

  New Ways to Support Childhood Cancer Survivors

  Chuck Green

• Free

  Novel Compound Restores Immune Response in Patients With Melanoma
• Free

  On Lists

  George W. Sledge MD

• Free

  Overlooked Immune Cells Hold Answers for Treating Aggressive Cancers
• Free

  Poetry Corner: From Boy to Oncologist

  Arjun Gupta MD

• Free

  Priority Review Designation for Rucaparib sNDA Granted
• Free

  Test to Detect Extensive Number of Biomarkers Approved
• Free

  UpToDate®
• Buy

  FDA Proposes Enforcement for Unproven Homeopathic Drugs
• Buy

  Immunotherapy Shows Promise in Treatment of Hodgkin Lymphoma

  Catlin Nalley

• Buy

  Management of QT Prolongation Risk in Cancer Patients

  Lisa K. Lohr PharmD, BCPS, BCOP

• Buy

  Shop Talk
• Buy

  The Blood-Brain Barrier: Brain Cancer Therapy Hits a Wall

  Choi-Fong Cho PhD